natgillin/translations-raw huggingface dataset:
Average starting HbA1c was 8.3%, and this fell to below 7% in 48.8% of those given Abasaglar, and 52.5% of those given Lantus, with an average percentage point fall of 1.29 and 1.34 respectively.
Povprečna vrednost HbA1c ob izhodišču je bila 8,3 % in je nato padla pod 7 % pri 48,8 % bolnikov, ki so prejemali zdravilo Abasaglar, in pri 52,5 % bolnikov, ki so prejemali zdravilo Lantus, pri čemer je povprečno znižanje znašalo 1,29 oziroma 1,34 odstotne točke.
Insulin glargine is slightly different from human insulin.
Insulin glargin se nekoliko razlikuje od človeškega insulina.
The dose is adjusted individually, and the patient's blood glucose (sugar) should be regularly tested to find the lowest effective dose.
Odmerek se prilagaja posamezniku, pri čemer je treba pri bolniku redno preverjati ravni glukoze (sladkorja) v krvi, da se določi najmanjši učinkoviti odmerek.
Other information about Abasaglar
Druge informacije o zdravilu Abasaglar
In both studies, the main measure of effectiveness was the change after 6 months of treatment in the level in the blood of a substance called glycosylated haemoglobin (HbA1c), which gives an indication of how well blood glucose is controlled.
V obeh študijah je bila glavno merilo učinkovitosti sprememba, ki so jo po šestih mesecih zdravljenja zabeležili v ravni snovi v krvi, imenovane glikozilirani hemoglobin (HbA1c), ki odraža uspešnost uravnavanja glukoze v krvi.
Why is Abasaglar approved?
Zakaj je bilo zdravilo Abasaglar odobreno?
What are the risks associated with Abasaglar?
Kakšna tveganja so povezana z zdravilom Abasaglar?
Studies were carried out to show that the way Abasaglar is absorbed into the body and the way it acts on blood glucose were similar to Lantus.
Izvedene so bile študije, v katerih so dokazovali, da sta način absorpcije zdravila Abasaglar v telesu in način njegovega delovanja na glukozo v krvi podobna kot pri zdravilu Lantus.
The active substance in Abasaglar, insulin glargine, is produced by a method known as ‘recombinant DNA technology': it is made by bacteria into which a gene (DNA) has been introduced that makes them able to produce insulin glargine.
Zdravilna učinkovina v zdravilu Abasaglar, insulin glargin, se proizvaja z metodo, imenovano „tehnologija rekombinantne DNK“, pri kateri so v bakterije vstavili gen (DNK), s katerim lahko tvorijo insulin glargin.
Their average HbA1c before treatment was 7.8% and the average fall after 6 months was similar (0.35% in the Abasaglar group and 0.46% in the Lantus group); 34.5% of those given Abasaglar, and 32.2% of those given Lantus were below the target of 7%.
Povprečna vrednost HbA1c pri teh bolnikih je bila pred zdravljenjem 7,8 %, povprečno znižanje po šestih mesecih pa je bilo podobno (0,35 % v skupini z zdravilom Abasaglar in 0,46 % v skupini z zdravilom Lantus); pri 34,5 % bolnikov, ki so prejemali zdravilo Abasaglar, in 32,2 % bolnikov, ki so prejemali zdravilo Lantus, so bile vrednosti pod ciljno vrednostjo 7 %.
The Agency's Committee for Medicinal Products for Human Use (CHMP) decided that, in accordance with EU requirements for biosimilar medicines, Abasaglar has been shown to have a comparable quality, safety and effectiveness to Lantus.
Odbor za zdravila za uporabo v humani medicini (CHMP) pri agenciji je zaključil, da je bilo v skladu z zahtevami EU glede podobnih bioloških zdravil dokazano, da je zdravilo Abasaglar po kakovosti,
Diabetes is a disease in which the body does not produce enough insulin to control the level of blood glucose.
Sladkorna bolezen je bolezen, pri kateri v telesu ne nastaja dovolj insulina za uravnavanje ravni glukoze v krvi.
What is Abasaglar and what is it used for?
Kaj je zdravilo Abasaglar in za kaj se uporablja?
For more information about treatment with Abasaglar, read the package leaflet (also part of the EPAR) or contact your doctor or pharmacist.
Za več informacij o zdravljenju z zdravilom Abasaglar preberite navodilo za uporabo (ki je prav tako del EPAR) ali se posvetujte z zdravnikom ali farmacevtom.
What benefits of Abasaglar have been shown in studies?
Kakšne koristi je zdravilo Abasaglar izkazalo v študijah?
Therefore, the CHMP's view was that, as for Lantus, the benefit outweighs the identified risk.
Zato je menil, da njegove koristi enako kot pri zdravilu Lantus odtehtajo znana tveganja.
Based on this plan, safety information has been included in the summary of product characteristics and the package leaflet for Abasaglar, including the appropriate precautions to be followed by healthcare professionals and patients.
V skladu s tem načrtom so bile v povzetek glavnih značilnosti zdravila Abasaglar in navodilo za njegovo uporabo vključene informacije o varnosti, vključno s previdnostnimi ukrepi, ki jih morajo upoštevati zdravstveni delavci in bolniki.
The reference medicine for Abasaglar is Lantus.
Referenčno zdravilo za zdravilo Abasaglar je zdravilo Lantus.
The replacement insulin acts in same way as naturally produced insulin and helps glucose enter cells from the blood.
Nadomestni insulin deluje enako kot naravno tvorjeni insulin in pomaga pri prehodu glukoze iz krvi v celice.
For the full list of all side effects and restrictions with Abasaglar, see the package leaflet.
Za celoten seznam neželenih učinkov in omejitev pri uporabi zdravila Abasaglar glejte navodilo za uporabo.
For practical information about using Abasaglar, patients should read the package leaflet or contact their doctor or pharmacist.
Za praktične informacije o uporabi zdravila Abasaglar naj bolniki preberejo navodilo za uporabo ali se posvetujejo z zdravnikom ali farmacevtom.
Abasaglar is available as cartridges and prefilled disposable pens (KwikPen) and can only be obtained with a prescription.
Zdravilo Abasaglar je na voljo v obliki vložkov in napolnjenih injekcijskih peresnikov za enkratno uporabo (KwikPen) ter se izdaja le na recept.
It is given by injection under the skin in the abdominal wall (tummy), the thigh, or the deltoid region (upper arm).
Zdravilo se daje z injiciranjem pod kožo v trebušno steno (trebuh), stegno ali deltoidni predel (nadlaket).
Abasaglar is a medicine that contains the active substance insulin glargine.
Abasaglar je zdravilo, ki vsebuje zdravilno učinkovino insulin glargin.
insulin glargine
Abasaglar insulin glargin
Abasaglar is a ‘biosimilar medicine'.
Zdravilo Abasaglar je „podobno biološko zdravilo“.
The Committee recommended that Abasaglar be given marketing authorisation.
Priporočil je, da se za zdravilo Abasaglar izda dovoljenje za promet.
• In one study, Abasaglar was compared with Lantus when added to short-acting insulin treatment in 536 patients with type 1 diabetes.
• V eni študiji so zdravilo Abasaglar in zdravilo Lantus, ki so ju dodajali zdravljenju s kratkodelujočim insulinom, primerjali pri 536 bolnikih s sladkorno boleznijo tipa 1.
Abasaglar is a replacement insulin that is very similar to the insulin made by the body.
Zdravilo Abasaglar je nadomestni insulin, ki je zelo podoben insulinu, ki nastaja v telesu.
Abasaglar can also be given together with diabetes medicines taken by mouth in patients who have type-2 diabetes.
Zdravilo Abasaglar se lahko pri bolnikih, ki imajo sladkorno bolezen tipa 2, uporablja tudi v kombinaciji z zdravili za zdravljenje sladkorne bolezni, ki se jemljejo skozi usta.
• In the second study, treatment with Abasaglar or Lantus was compared in 759 patients with type 2 diabetes, as an addition to diabetes medicines taken by mouth.
• V drugi študiji so primerjali zdravilo Abasaglar in zdravilo Lantus, ki so ju dodajali zdravilom za zdravljenje sladkorne bolezni, ki se jemljejo skozi usta, pri 759 bolnikih s sladkorno boleznijo tipa 2.
How is Abasaglar used?
Kako se zdravilo Abasaglar uporablja?
In addition, treatment with once-daily Abasaglar has been shown to be comparable to the reference medicine, Lantus, in two supportive studies involving a total of 1,295 adults with diabetes.
Poleg tega sta dve podporni študiji, v katerih je sodelovalo skupno 1 295 odraslih s sladkorno boleznijo, pokazali, da je zdravljenje z zdravilom Abasaglar enkrat na dan primerljivo zdravljenju z referenčnim zdravilom Lantus.
How does Abasaglar work?
Kako zdravilo Abasaglar deluje?
LIST OF THE NAMES, PHARMACEUTICAL FORMS, STRENGTHS OF THE MEDICINAL PRODUCTS, ROUTES OF ADMINISTRATION, MARKETING AUTHORISATION HOLDERS IN THE MEMBER STATES
DODATEK I SEZNAM IMEN, FARMACEVTSKIH OBLIK, JAKOSTI ZDRAVILA, POTI UPORABE ZDRAVILA, PREDLAGATELJEV,IMETNIKOV DOVOLJENJA ZA PROMET Z ZDRAVILOM V DRŽAVAH ČLANICAH
Cineole + Camphor + Gomenol (Niaouli oil)
Cineol + Kafra + Gomenol (Niaouli oil)
LABORATOIRES JOLLY JATEL 28 avenue Carnot 78951 Saint-Germain en Laye Cedex France
LABORATOIRES JOLLY JATEL 28 avenue Carnot 78951 Saint-Germain en Laye Cedex
SPINDLER 6, Avenue de l'Europe BP51
LABORATOIRES MAYOLY SPINDLER 6, Avenue de l'Europe BP51
CAMPHOCAL YPTOL SIMPLE ENFANTS 0,07 g, suppositoire
CAMPHOCALYPT OL SIMPLE ENFANTS 0,07 g, suppositoire
BI-QUI-NOL ENFANTS, suppositoire camphre racémique, cinéole
BI-QUI-NOL ENFANTS, suppositoire kafra racémique, cineol
Meda PharmaProdutos farmacêuticos, S.A. Rua do Centro Cultural, 13 1749-066 Lisboa
Rua do Centro Cultural, 13 1749-066 Lisboa
92503 RUEIL MALMAISON CEDEX
92503 RUEIL MALMAISON CEDEX France
CAMPHOCAL YPTOL SIMPLE NOURRISSON S 0,06 g, suppositoire
CAMPHOCALYPT OL SIMPLE NOURRISSONS 0,06 g, suppositoire
OZOTHINE ENFANTS 30 mg, suppositoire terebenthine (huile essentielle de)
OZOTHINE ENFANTS 30 mg, suppositoire eterično olje iz terpentina
Lipobalsamo Eucalyptol/ guaiacol
Eucalyptol/ guaiakol
Ozopulmin Oxidation product of turpentine/pine essential oil
Ozopulmin oksidacijski produkt terpentina / Eterično olje bora
HEXAPNEUMI NE
BRONCHODERMI NE
BRONCHOREC TINE AU CITRAL ENFANTS, suppositoire terpinol, pin, serpolet
BRONCHORECTIN E AU CITRAL ENFANTS, suppositoire terpineol, bor, serpolet
1-13 boulevard Romain Rolland 75014 Paris France
1-13 boulevard Romain Rolland
eucalyptus huile essentielle thiophene carboxylate paracetamo
eterično olje iz evkaliptusa thiophene carboxylate paracetamol
BRONCHOREC TINE AU CITRAL NOURRISSON S, suppositoire terpinol, pin, serpolet
BRONCHORECTIN E AU CITRAL NOURRISSONS, suppositoire terpineol, bor , serpolet
Eucalyptine Lebrun eucalyptol inn:codéine phosphate
Eucalyptine Lebrun evkaliptol codéine phosphate
Trophires Enfants eucalyptus huile essentielle thiophene carboxylate paracetamo
Trophires Enfants eterično olje iz evkaliptusa thiophene carboxylate paracetamol
Camphor + Eucalyptol + Menthol
Kafra + Evkaliptol + Mentol
EucalyptinePholcodine Enfants camphre eucalyptol gaiacol phenol pholcodine
Eucalyptine Pholcodine Child kafra evkaliptol guaiacol pholcodine phenol
Trophires Compose Nourrissons paracetamol essence d'eucalyptus tenoate de sodium
Trophires Compose Nourrissons paracetamol eterično olje iz evkaliptusa tenoate de sodium
TERPONE ENFANTS, suppositoire niaouli, huile essentielle d'eucalyptus, terpine, huile essentielle d'aiguilles de pin de siberie
TERPONE ENFANTS, suppositoire niaouli, eterično olje iz evkaliptusa, terpin, eterično olje bora
FEBRECTOL ENFANTS, suppositoire pin
FEBRECTOL ENFANTS, suppositoire bor
TERPONE NOURRISSON S, suppositoire niaouli, huile essentielle d'eucalyptus, terpine, huile essentielle d'aiguilles de pin de siberie
TERPONE NOURRISSONS, suppositoire niaouli, eterično olje iz evkaliptusa, terpin, eterično olje bora
TROPHIRES NOURRISSON S, suppositoire huile essentielle d'eucalyptus
TROPHIRES NOURRISSONS, suppositoire eterično olje iz evkaliptusa
BRONCHODE RMINE ENFANTS, suppositoire cinéole, huile essentielle de pin
BRONCHODERMI NE ENFANTS, suppositoire cineol, eterično olje bora
TROPHIRES COMPOSE ENFANTS, suppositoire huile essentielle d'eucalyptus
TROPHIRES COMPOSE ENFANTS, suppositoire eterično olje iz evkaliptusa
FEBRECTOL NOURRISSON S, suppositoire pin
FEBRECTOL NOURRISSONS, suppositoire bor
BOUCHARA RECORDATI 38 rue MarjolinBP67
BOUCHARA RECORDATI 38 rue Marjolin - BP67 92302 Levallois-Perret Cedex
TROPHIRES ENFANTS, suppositoire huile essentielle d'eucalyptus
TROPHIRES ENFANTS, suppositoire eterično olje iz evkaliptusa
30,500 28802 Alcalá de Henares (Madrid) Spain
Alcalá de Henares (Madrid)
Trophires Bebes eucalyptus huile essentielle tenuate de sodium
Trophires Bebes eterično olje iz evkaliptusa tenuate de sodium
TROPHIRES COMPOSE NOURRISSON S, suppositoire huile essentielle d'eucalyptus
TROPHIRES COMPOSE NOURRISSONS, suppositoire eterično olje iz evkaliptusa
DIPROPHYLLI NE ENFANTS, suppositoire terebenthine (huile essentielle de)
OZOTHINE A LA DIPROPHYLLINE ENFANTS, suppositoire eterično olje iz terpentina
Eucalyptine camphora inn:eucalyptol inn:guaiacol
Eucalyptine kafra evkaliptol guaiacol
BRONCHODE RMINE NOURRISSON S, suppositoire cinéole, huile essentielle de pin
NOURRISSONS, suppositoire cineol, eterično olje bora
This can lead to weakness or even paralysis.
Posledica tega je lahko oslabelost ali celo paraliza.
Overall Population (n=237)
Vsa populacija (n = 237)
Carcinogenicity studies have not been performed.
Raziskave kancerogenosti niso bile izvedene.
The powder will not dissolve.
Prašek se ne bo raztopil.
It should not be taken in its dry form.
Ne sme se ga zaužiti v suhi obliki.
Elderly population (≥65 years of age)
Starejša populacija (starost ≥ 65 let)
Long term exposure
Dolgoročna izpostavljenost
DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION Date of first authorisation: 19 July 2017
DATUM PRIDOBITVE/PODALJŠANJA DOVOLJENJA ZA PROMET Z ZDRAVILOM Datum prve odobritve: 19 julij 2017
Clinical trials with patiromer have not included exposure longer than one year.
Klinični preskusi s patiromerom niso vključevali izpostavljenosti, daljše od enega leta.
The safety and efficacy of Veltassa in children aged under 18 years have not yet been established.
Varnost in učinkovitost zdravila Veltassa pri otrocih, starih manj kot 18 let, še nista bili dokazani.
4.5 Interaction with other medicinal products and other forms of interaction Effect of patiromer on other medicinal products
4.5 Medsebojno delovanje z drugimi zdravili in druge oblike interakcij Vpliv patiromera na druga zdravila
Effect of Food
Vpliv hrane
Study Visit (week)
Obisk v okviru študije (teden)
Too much potassium in the blood can affect how your nerves control your muscles.
Preveč kalija v krvi lahko vpliva na to, kako živci nadzirajo mišice.
• if you are allergic to patiromer or any of the other ingredients of this medicine (listed in section 6).
• če ste alergični na patiromer ali katero koli sestavino tega zdravila (navedeno v poglavju 6).
Calcium is partially released some of which may be absorbed (see section 5.1).
Kalcij se delno sprošča, nekaj od tega pa se ga lahko absorbira (glejte poglavje 5.1).
Do not give Veltassa to children under 18 years, as it has not been studied in this age group.
Zdravila Veltassa ne dajajte otrokom, mlajšim od 18 let, saj zdravila pri tej starostni skupini niso preučili.
It should not replace emergency treatment for life threatening hyperkalaemia.
Ne sme se ga nadomestiti nujnega zdravljenja pri življenjsko ogrožajoči hiperkaliemiji.
Due to the insolubility and nonabsorptive characteristics of this medicinal product, many classical pharmacokinetic studies cannot be carried out.
Zaradi netopnosti in neabsorptivnih značilnosti tega zdravila ni mogoče izvesti večine klasičnih farmakokinetičnih študij.
Do not take Veltassa as a dry powder.
Zdravila Veltassa ne jemljite kot suh prašek.
Patients should be instructed not to discontinue therapy without consulting their physicians.
Bolnikom je treba naročiti, naj zdravljenja ne prekinejo, ne da bi se pred tem posvetovali s svojim zdravnikom.
very common (≥1/10), common (≥1/100 to <1/10) and uncommon (≥1/1,000 to <1/100), rare (≥1/10,000 to <1/1,000), very rare (<1/10,000), not known (cannot be estimated from the available data).
Pogostnosti neželenih učinkov so opredeljene kot: zelo pogosti (≥ 1/10), pogosti (≥ 1/100 do < 1/10), občasni (≥ 1/1.000 do < 1/100), redki (≥ 1/10.000 do < 1/1.000), zelo redki (< 1/10.000) in neznana (ni mogoče oceniti iz razpoložljivih podatkov).
Pack sizes: boxes of 30, 60 or 90 sachets.
Velikosti pakiranja: škatle po 30, 60 ali 90 vrečic.
Within each frequency grouping, undesirable effects are presented in order of decreasing seriousness.
V vsaki razvrstitvi pogostnosti so neželeni učinki navedeni po padajoči resnosti.
• had major surgery on your stomach or bowel.
• če ste imeli večjo operacijo na želodcu ali črevesju.
As patiromer is not absorbed or metabolised by the body, there are limited effects on the function of other medicinal products.
Ker se patiromer ne absorbira ali presnovi v telesu, obstajajo omejeni učinki na delovanje drugih zdravil.
However, there was no interaction when patiromer and these medicinal products were taken 3 hours apart.
Do medsebojnega delovanja pa ni prišlo v primeru, ko so bila ta zdravila in patiromer vzeti 3 ure narazen.
Patients with rare hereditary problems of fructose intolerance should not take this medicine.
Bolniki z redko dedno fruktozno intoleranco tega zdravila ne smejo jemati.
Take the prepared Veltassa suspension with or without food, preferably at the same time each day.
Pripravljeno suspenzijo zdravila Veltassa vzemite skupaj s hrano ali brez nje, po možnosti vsak dan ob istem času.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
Če vam je zdravnik povedal, da imate intoleranco na nekatere sladkorje, se posvetujte z zdravnikom, preden vzamete to zdravilo.
The marketing authorisation holder shall submit the first periodic safety update report for this product within 6 months following authorisation
Imetnik dovoljenja za promet z zdravilom mora prvo redno posodobljeno poročilo o varnosti zdravila za to zdravilo predložiti v 6 mesecih po pridobitvi dovoljenja za promet.
The daily dose may be increased or decreased by 8.4 g as necessary to reach the desired target range, up to a maximum dose of 25.2 g daily.
Dnevni odmerek je dovoljeno povečati ali zmanjšati za 8,4 g, kot je potrebno za doseganje želenega ciljnega območja, vendar največ do odmerka 25,2 g na dan.
The complete dose should be poured into a glass containing approximately 40 mL of water, then stirred.
Celotni odmerek se vsuje v kozarec, ki vsebuje približno 40 ml vode, in se nato premeša.
4.7 Effects on ability to drive and use machines Patiromer has no or negligible influence on the ability to drive and use machines.
4.7 Vpliv na sposobnost vožnje in upravljanja strojev Patiromer nima vpliva ali ima zanemarljiv vpliv na sposobnost vožnje in upravljanja strojev.
As a precautionary measure, it is preferable to avoid the use of patiromer during pregnancy.
Iz preventivnih vzrokov je priporočljivo, da se v času nosečnosti izognete uporabi patiromera.
No effects on the breast fed newborn/infant are anticipated since the systemic exposure of the breastfeeding woman to patiromer is negligible.
Učinkov na dojene novorojenčke/dojenčke ni pričakovati, saj je sistemska izpostavljenost doječih žensk patiromeru zanemarljiva.
• Drink the mixture within 1 hour after preparation.
• Mešanico popijte v 1 uri po pripravi.
• You may add more water to the mixture to help you swallow the medicine.
• Mešanici lahko dodate več vode, da boste zdravilo lažje popili.
Veltassa is available in packs containing 30, 60 or 90 sachets.
Zdravilo Veltassa je na voljo v pakiranjih po 30, 60 ali 90 vrečic.
In Part A, 243 patients were treated with patiromer for 4 weeks.
V delu A so 243 bolnikov 4 tedne zdravili s patiromerom.
Higher K+ Stratum:
Višji sloj K+:
If you miss more than one dose, contact your doctor.
Če pozabite vzeti več kot en odmerek, se posvetujte s svojim zdravnikom.
If you are pregnant or breast feeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.
Nosečnost in dojenje Če ste noseči ali dojite, menite, da bi lahko bili noseči ali načrtujete zanositev, se posvetujte z zdravnikom ali farmacevtom, preden vzamete to zdravilo.
Other medicines and Veltassa
Druga zdravila in zdravilo Veltassa
Quantitative whole-body autoradiography analysis in rats demonstrated that radioactivity was limited to the gastrointestinal tract, with no detectable level of radioactivity in any other tissues or organs.
Kvantitativna avtoradiografska analiza celega telesa je pri podganah pokazala, da je bila radioaktivnost omejena na gastrointestinalni trakt, pri čemer ni bilo zaznavnih stopenj radioaktivnosti v nobenem drugem tkivu ali organu.
You can use apple juice or cranberry juice instead of water.
Namesto vode lahko uporabite jabolčni ali brusnični sok.
There are no data on the effect of patiromer on fertility in humans.
Ni podatkov o vplivu patiromera na plodnost pri ljudeh.
Animal studies showed no effects on reproductive function or fertility (see section 5.3).
Študije na živalih niso pokazale vpliva na reproduktivno funkcijo ali plodnost (glejte poglavje 5.3).
A decision must be made whether to discontinue breast feeding or to discontinue/abstain from patiromer therapy taking into account the benefit of breast feeding for the child and the benefit of therapy for the woman.
Treba se je odločiti, ali bo bolnica prenehala dojiti ali prenehala/prekinila zdravljenje s patiromerom, pri čemer je treba pretehtati koristi dojenja za otroka in koristi zdravljenja za žensko.
Use Veltassa during pregnancy and breast feeding only if your doctor considers it necessary.
Zdravilo Veltassa v času nosečnosti in dojenja vzemite samo, če vaš zdravnik meni, da je to potrebno.
If serum potassium falls below the desired range, the dose should be reduced or discontinued.
Če raven kalija v serumu pade pod želeno območje, je treba odmerek zmanjšati ali ukiniti.
• Add the required number of Veltassa sachets and stir.
• Dodajte potrebno število vrečic zdravila Veltassa in pomešajte.
High potassium levels can also result in an abnormal heartbeat, which can cause serious effects on your heart rhythm.
Posledica visokih ravni kalija je lahko tudi nenormalen srčni utrip, ki resno vpliva na srčni ritem.
If it is determined that medical intervention is required, appropriate measures to restore serum potassium may be considered.
Če se ugotovi, da je potrebna zdravstvena intervencija, je treba razmisliti o ustreznih ukrepih za obnovitev ravni kalija v serumu.
The powder does not dissolve but forms a suspension, which might feel grainy.
Prašek se ne bo raztopil, bo pa nastala suspenzija, ki se bo morda zdela zrnata.
Your doctor may adjust the dose depending on the potassium level in your blood.
Vaš zdravnik lahko odmerek prilagodi, odvisno od ravni kalija v vaši krvi.
Another approximately 40 mL of water should be added, and the suspension stirred again thoroughly.
Zatem se doda še približno 40 ml vode ter suspenzijo znova temeljito premeša.
Date when taken out of the refrigerator:______
Zabeležite datum, ko zdravilo vzamete iz hladilnika: ______
Veltassa can be taken with or without food.
Zdravilo Veltassa lahko vzamete skupaj s hrano ali brez nje.
Increases in serum potassium may occur as early as 2 days after the last patiromer dose.
Ravni kalija v serumu se lahko zvišajo že 2 dni po zadnjem vzetem odmerku patiromera.
If powder remains in the glass after drinking, more water should be added and the suspension stirred and taken immediately.
Če po pitju v kozarcu ostane prašek, dodajte vodo, je treba premešati suspenzijo in jo takoj popiti.
92042 Paris La Défense Cedex France
92042 Paris La Défense Cedex Francija
In general, cranberry juice intake should be limited to moderate amounts (for example less than 400 mL per day) due to its potential interaction with other medicinal products.
Na splošno je treba uživanje brusničnega soka omejiti na zmerne količine (na primer manj kot 400 ml na dan), saj lahko medsebojno deluje z drugimi zdravili.
Veltassa may affect certain medicines if they are taken by mouth and at the same time, such as:
Zdravilo Veltassa lahko vpliva na določena zdravila, če jih vzamete peroralno (zaužijete) ob istem času, na primer:
Low Magnesium
Nizka raven magnezija
The recommended starting dose is 8.4 g patiromer once daily.
Priporočen začetni odmerek je 8,4 g patiromera enkrat na dan.
powder for oral suspension 30 sachets
prašek za peroralno suspenzijo 30 vrečic